us en false false Default

CNXT

VanEck
ChiNext ETF

As of November 30, 2025

Fund Details

Fund Ticker CNXT
Intraday NAV (IIV) CNXTIV
Index Ticker SZ988107
Total Net Assets ($M) 41.81
Options Available
Exchange NYSE Arca
Inception Date 07/23/14

Fund Data

Number of Holdings 99
Currency USD
Price/Earnings Ratio* 36.32
Price/Book Ratio* 5.23
Weighted Avg. Market Cap ($M) $70,943
30-Day SEC Yield * 0.14%
NAV: 52 Week High/Low $45.18/$23.33
*30-Day SEC Yield is based on the most recent 30-day period and reflects the investment income earned after deducting a fund’s expenses for the period. This yield does not necessarily reflect the yield that an investor will receive. Distributions may vary from time to time. A weighted harmonic average is used to calculate this metric. Price/Book Ratio is the price of a security divided by the book value per share of the security. Price/Earnings Ratio is the price of a security divided by the last twelve months earnings per share of the security. 

Fees and Expenses

Management Fee 0.50%
Other Expenses 0.77%
Gross Expense Ratio 1.27%
Fee Waivers and
Expense Reimbursement		 -0.62%
Net Expense Ratio 0.65%

Expenses for CNXT are capped contractually at 0.65% until May 1, 2026. Cap excludes acquired fund fees and expenses, trading expenses, taxes and extraordinary expenses.

About CNXT

VanEck ChiNext ETF (CNXT®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the ChiNext Index (SZ988107), which tracks the performance of the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The ChiNext Index is comprised of China A-shares (“A-shares”).

Top 10 Holdings

Holding Name
Ticker
 % of Net Assets
Contemporary Amperex Technology Co Ltd
300750 C2
 19.92
Zhongji Innolight Co Ltd
300308 C2
 9.26
Eoptolink Technology Inc Ltd
300502 C2
 6.34
East Money Information Co Ltd
300059 C2
 6.06
Sungrow Power Supply Co Ltd
300274 C2
 5.54
Victory Giant Technology Huizhou Co Ltd
300476 C2
 3.42
Shenzhen Inovance Technology Co Ltd
300124 C2
 2.90
Shenzhen Mindray Bio-Medical Electronic
300760 C2
 2.31
Wens Foodstuffs Group Co Ltd
300498 C2
 1.99
Eve Energy Co Ltd
300014 C2
 1.87
Top 10 Total 59.59
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Performance History:

Average Annual Total Returns* (%)

Month End as of 11/30/25 1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
07/23/14
CNXT (NAV) -2.89 7.39 50.52 41.87 10.56 0.83 1.04 5.65
CNXT (Share Price) -2.83 6.54 52.04 41.99 10.51 0.96 1.02 5.66
SZ988107 (Index) -3.63 6.61 49.52 42.27 10.88 0.89 2.41 7.31
Performance Differential (NAV - Index) 0.74 0.78 1.00 -0.40 -0.32 -0.06 -1.37 -1.66
Quarter End as of 09/30/25 1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
07/23/14
CNXT (NAV) 12.76 52.03 58.05 53.10 14.10 3.23 3.59 6.20
CNXT (Share Price) 12.36 54.11 60.35 50.26 14.26 3.52 3.66 6.25
SZ988107 (Index) 12.10 51.25 57.23 48.05 13.35 3.55 4.75 7.91
Performance Differential (NAV - Index) 0.66 0.78 0.82 5.05 0.75 -0.32 -1.16 -1.71

*Returns less than one year are not annualized.

As of October 1, 2015, index data for the SME-ChiNext 100 Index (the “Index”) for all periods presented reflect the CNI6109 stream of the Index which is denominated in USD and converted by the index provider using the “offshore” Renminbi (CNH) exchange rate. Returns reflect temporary contractual fee waivers and/or expense reimbursements. From December 10, 2021 forward, the index data reflects that of the Fund's underlying index, the ChiNext Index (SZ988107), and is not intended for third party use.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

The Fund’s prospectus has not been submitted for approval to the Belgian Financial Services and Markets Authority (Autoriteit voor Financiële Diensten en Markten / Autorité des Services et Marchés Financiers) and, accordingly, the shares may not be distributed by way of public offering in Belgium and may only be offered to a maximum of 99 investors or to institutional and professional investors (as defined in Article 5, §3 of the Law of July 20, 2004, and as extended by the provisions of the Belgian Royal Decree of September 26, 2006 . These materials may be distributed in Belgium only to such prospective investors for their personal use and may not be used for any other purpose or passed on to any other person in Belgium. Shares will only be offered to such qualifying prospective investors.

In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck ChiNext ETF would have been -0.04% on 11/30/25.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

The "Net Asset Value" (NAV) of a Fund is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. Investors should not expect to buy or sell shares at NAV.

CNXT

VanEck
ChiNext ETF

As of November 30, 2025

Top 10 Countries

Country % of Net Assets
China 97.68
United Kingdom 2.31
Other/Cash 0.01
Top 10 Total 100.00

Sector Weightings

Sector % of Net Assets
■ Information Technology 37.0
■ Industrials 36.0
■ Health Care 8.9
■ Financials 8.3
■ Materials 3.7
■ Consumer Staples 3.0
■ Communication Services 2.4
■ Consumer Discretionary 0.7
■ Other/Cash 0.0

Index returns are not Fund returns and do not reflect any management fees or brokerage expenses. Certain indices may take into account withholding taxes. Investors can not invest directly in the Index. Index returns assume that dividends have been reinvested.

An investment in the Fund may be subject to risks which include, but are not limited to, risks related to the Fund’s principal investment strategies, health care sector, industrials sector, information technology sector, financials sector, special risk considerations of investing in China and Chinese-issued A-shares, ChiNext Market, Stock Connect, PRC tax, foreign securities, emerging market issuers, foreign currency, medium-capitalization companies, cash transactions, equity securities, market, operational, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount, liquidity of fund shares, non-diversification, index-related concentration and high portfolio turnover risks, all of which may adversely affect the Fund. Emerging market issuers and foreign securities may be subject to securities markets, political and economic, investment and repatriation restrictions, different rules and regulations, less publicly available financial information, foreign currency and exchange rates, operational and settlement, and corporate and securities laws risks. Medium-capitalization companies may be subject to elevated risks. Investments in China may also be subject to risks which include political and economic, inflation, tax changes, nationalization and expropriation, Hong Kong policy, Chinese securities markets, less stringent disclosure, regulatory standards, and publicly available information on Chinese issuers, and Chinese corporate and securities law risks Investments in Chinese-issued A-shares may also be subject to risks related to investment and repatriation restrictions, loss of favorable U.S. tax treatment, tax on retained income and gains, foreign exchange control, custody risks, foreign currency considerations, and China-related index tracking risks.

ChiNext Index and its logo are service marks of Shenzhen Securities Information Co., Ltd. ("SSI") and have been licensed for use by Van Eck Associates Corporation. The VanEck ChiNext ETF is not sponsored, endorsed, sold or promoted by SSI and SSI makes no representation regarding the advisability of investing in the VanEck ChiNext ETF.

Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of the Fund carefully before investing. To obtain a prospectus and summary prospectus, which contains this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.

This content is published in the United States for residents of specified countries. Investors are subject to securities and tax regulations within their applicable jurisdictions that are not addressed on this content. Nothing in this content should be considered a solicitation to buy or an offer to sell shares of any investment in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction, nor is it intended as investment, tax, financial, or legal advice. Investors should seek such professional advice for their particular situation and jurisdiction.

Van Eck Securities Corporation, Distributor, a wholly-owned subsidiary of Van Eck Associates Corporation | 666 Third Avenue | New York, NY 10017 

FUND TICKER: CNXT 800.826.2333 VANECK.COM